J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2007

Papers In Press, published online ahead of print October 30, 2006
J. Lipid Res., doi:10.1194/jlr.M600365-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M600365-JLR200v1
48/1/127    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaikh, S. R.
Right arrow Articles by Edidin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaikh, S. R.
Right arrow Articles by Edidin, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on August 16, 2006
Revised on October 30, 2006
Accepted on October 30, 2006

Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by HLA class I molecules

Saame Raza Shaikh and Michael Edidin

Biology, Johns Hopkins University, Baltimore, MD 21218

Corresponding Author: saameshaikh{at}gmail.com

Dietary supplementation with polyunsaturated fatty acids (PUFAs) has immunosuppressive effects; however, the molecular targets of PUFAs and their mode of action remain unclear. One possible target is antigen presentation to T cells through the HLA class I pathway. Here we show that incorporation of PUFAs lowers target cell susceptibility to lysis by effector T cells. Treatment of B lymphoblast targets with the -6 PUFA arachidonic acid (AA) or -3 docosahexaenoic acid (DHA) lowered their susceptibility to lysis by alloreactive CD8+ T cells by ~20-25%. HLA class I surface levels and their rate of ER-Golgi traffic were also reduced by PUFA treatment. Calibration experiments showed the ~15% reduction in surface HLA I was not sufficient to completely account for the decreased lysis. However, PUFAs significantly lowered APC-T cell conjugate formation, by ~30-40%. Taken together, our data show for the first time that an -6 and an -3 PUFA affect the HLA class I pathway of B lymphoblasts. Our findings suggest elimination of self and pathogen derived peptides by effectors may be compromised by dietary PUFA supplementation. In addition, PUFA mediated changes in ER-Golgi trafficking point to a new area of PUFA modulation of immune responses.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.